CMB International Capital Corporation

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 66
Average round size
info
The average size of a deal this fund participated in
$109M
Portfolio companies 58
Rounds per year 1.89
Lead investments 18
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 5
Key employees 1
Stages of investment
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Medical
Summary

CMB International Capital Corporation is the famous VC, which was founded in 1987. The fund was located in Asia if to be more exact in Hong Kong. The main department of described VC is located in the Central.

Among the most popular portfolio startups of the fund, we may highlight CMC Capital Group, Guazi (Chehaoduo), United Imaging Healthcare. For fund there is no match between the location of its establishment and the land of its numerous investments - China. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Diagnostics, Artificial Intelligence. The fund has specific favorite in a number of founders of portfolio startups.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the CMB International Capital Corporation, startups are often financed by Sequoia Capital China, SDIC Venture Capital, Legend Star. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, SDIC Venture Capital, SDIC Fund Management. In the next rounds fund is usually obtained by DST Global, Tencent Holdings, Taihe Capital.

The overall number of key employees were 1.

Deals in the range of more than 100 millions dollars are the general things for fund. The top amount of exits for fund were in 2019. The high activity for fund was in 2019. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this CMB International Capital Corporation works on 24 percentage points less the average amount of lead investments. When the investment is from CMB International Capital Corporation the average startup value is more than 1 billion dollars. The fund is constantly included in 7-12 investment rounds annually.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CMB International Capital Corporation:
Typical Co-investors
CMB International Capital Corporation is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CMB International Capital Corporation:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Huashun Xin'an

Big Data
Cyber Security
Network Security
19 Apr 2022 Beijing, Beijing, China

Rona Therapeutics

Health Care
Medical
Therapeutics
$33M07 Apr 2022 Shanghai, Shanghai, China

METiS Pharmaceuticals

Artificial Intelligence
$150M06 Apr 2022 Shangcheng District, Zhejiang, China

METiS Therapeutics

Biopharma
Biotechnology
Genetics
Health Care
$75M05 Apr 2022 Cambridge, Massachusetts, United States

HemaCell

$15M25 Feb 2022 -

ABclonal

Biometrics
Biopharma
Biotechnology
$185M08 Dec 2021 Woburn, Massachusetts, United States

Jiahe Jinwei

Computer
Consumer Electronics
Electronics
Hardware
Manufacturing
26 Nov 2021 Shenzhen, Guangdong, China

Neurophth Therapeutics

Biotechnology
Life Science
$60M23 Nov 2021 Jiang'an District, Hubei, China

Ultraleap

Consumer Electronics
Electronics
Software Engineering
Virtual Reality
$82M17 Nov 2021 Bristol, England, United Kingdom
News
Inceptio Technology Raises US$270M in Series B Financing

– Inceptio Technology is a Shangai, China-based autonomous driving truck technology and operating company.
– Company closed a US$270m Series B equity financing.
– The round was led by JD Logistics (02618.HK), Meituan (03690.HK), and PAG with participation from Deppon Express (603056.SH), IDG Capital, CMB International, SDIC, Mirae Asset, Eight Roads, and Broad Vision Funds, as well as existing shareholders GLP Hidden Hill Capital, CATL (300750.SZ), NIO Capital and Eastern Bell Capital.
– The company intends to use the funds to accelerate the development of its self-developed full-stack autonomous driving system “Xuanyuan”, and speed up its deployment in electrification.

Qihan Biotech Raises Additional USD 67 Million in Series A++ Financing

– Qihan Biotechnology Co. Ltd, a leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced today that it has raised an additional $67 million in Series A++ financing.
– Proceeds from the financing will primarily be used to advance Qihan’s pipeline of novel cell therapies in IND-enabling studies and hypoimmunity projects, and expansion of the company’s GMP manufacturing facilities.
– The financing was backed by new investors including leading biomedical venture capital firm, Lilly Asia Ventures and Matrix Partners China, as well as existing shareholders, Sequoia and CMB International.
– With these investments, Qihan’s total Series A financing raised to date has exceeded $100 million.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CMB International Capital Corporation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: